Condition: Neonatal Thrombocytopenia · Bleeding · Sponsor: Karolinska Institutet
This is a prospective observational study designed to evaluate Immature Platelet Fraction or Immature Platelet Count and Platelet Function Analyzer-100/200 Closure Time-ADP (in vitro bleeding time) as markers of bleeding risk in thrombocytopenic preterm neonates admitted to the Neonatal Intensive Care Unit.
This description comes directly from the study's public registry record.
Emöke Deschmann, MD, PhD · +46 73 539 5575 · emoke.deschmann@regionstockholm.se
Martha Sola-Visner, MD · 617-919-4845 · martha.sola-visner@childrens.harvard.edu
Always discuss trial participation with your own doctor first.
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | Not Yet Recruiting |
| Intermountain Medical Center | Murray, Utah, United States | Not Yet Recruiting |
| Utah Valley Hospital | Provo, Utah, United States | Not Yet Recruiting |
| Amsterdam University Medical Centre | Amsterdam, Netherlands | Not Yet Recruiting |
| Leiden University Medical Center | Leiden, Netherlands | Not Yet Recruiting |
| Karolinska University Hospital Huddinge campus | Huddinge, Sweden | Recruiting |
| Karolinska University Hospital Solna campus, Astrid Lindgren Children's Hospital | Stockholm, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04598750